Alexion Pharmaceuticals, Inc.

CIK 899866 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alexion Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 16, 2022SC TO-T/A0001104659-22-119357
Oct 18, 2022SC TO-T0001104659-22-109684
Oct 3, 2022SC TO-C0001104659-22-105322
Aug 9, 2021SC 13G/A0000834237-21-008917
Aug 2, 202115-12G0001104659-21-098595
Jul 23, 202140000899866-21-000070
Jul 23, 202140000899866-21-000065
Jul 23, 202140000899866-21-000077
Jul 23, 202140000899866-21-000074
Jul 23, 202140000899866-21-000067
Jul 23, 2021EFFECT9999999995-21-002893
Jul 23, 202140000899866-21-000068
Jul 23, 202140000899866-21-000069
Jul 23, 202140000899866-21-000066
Jul 23, 202140000899866-21-000075
Jul 23, 2021EFFECT9999999995-21-002907
Jul 23, 2021EFFECT9999999995-21-002891
Jul 23, 2021EFFECT9999999995-21-002909
Jul 23, 202140000899866-21-000071
Jul 23, 202140000899866-21-000073
Jul 23, 2021EFFECT9999999995-21-002908
Jul 23, 202140000899866-21-000064
Jul 23, 2021EFFECT9999999995-21-002905
Jul 23, 2021EFFECT9999999995-21-002904
Jul 23, 2021EFFECT9999999995-21-002906